Development and validation of serum bilirubin nomogram to predict the absence of risk for severe hyperbilirubinaemia before discharge: A prospective, multicenter study

Italian Journal of Pediatrics

Volumn 38, Issue 1, 2012, Pages

  Romagnoli, Costantino ^a   Tiberi, Eloisa ^a   Barone, Giovanni ^a   Curtis, Mario De ^b   Regoli, Daniela ^b   Paolillo, Piermichele ^c   Picone, Simonetta ^c   Anania, Stefano ^d   Finocchi, Maurizio ^e   Cardiello, Valentina ^a   Giordano, Lucia ^a   Paolucci, Valentina ^a   Zecca, Enrico ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Casilino General Hospital   (Italy)

^d Liverp P H Ibrahim   (Italy)

^e Neonatal Unit   (Italy)

Author keywords

hyperbilirubinemia; jaundice; newborn babies; predictive nomogram

Indexed keywords

BILIRUBIN;

ARTICLE; BILIRUBIN BLOOD LEVEL; FALSE NEGATIVE RESULT; FEMALE; GESTATIONAL AGE; HOSPITAL DISCHARGE; HUMAN; HYPERBILIRUBINEMIA; MALE; NEWBORN; NOMOGRAM; PREDICTIVE VALUE; RISK ASSESSMENT; BLOOD; CLINICAL TRIAL; MULTICENTER STUDY; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; VALIDATION STUDY;

BILIRUBIN; FEMALE; HUMANS; HYPERBILIRUBINEMIA; INFANT, NEWBORN; MALE; NOMOGRAMS; PATIENT DISCHARGE; PROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84860549045     PISSN: 17208424     EISSN: 18247288     Source Type: Journal    
DOI: 10.1186/1824-7288-38-6     Document Type: Article

References (39)

1. Length of stay, jaundice, and hospital readmission. Maisels MJ, Kring E, Pediatrics 1998 101 995 8 10.1542/peds.101.6.995 9606225 (Pubitemid 28248883)
2. Discharge criteria for the term newborn. Friedman MA, Spitzer AR, Pediatr Clin North Am 2004 51 3 599 618 10.1016/j.pcl.2004.01.011 15157587 (Pubitemid 38638550)
3. Improving newborn preventive services at the birth hospitalization: a collaborative, hospital-based quality-improvement project. Mercier CE, Barry SE, Paul K, Delaney TV, Horbar JD, Wasserman RC, Berry P, Shaw JS, Pediatrics 2007 120 481 8 10.1542/peds.2007-0233 17766519 (Pubitemid 47358289)
4. Association between duration of neonatal hospital stay and readmission rate. Lee K-S, Perlman M, Ballantyne M, J Pediatr 1995 127 758 66 10.1016/S0022-3476(95)70170-2 7472833
5. Hospital readmission due to neonatal hyperbilirubinemia. Seidman DS, Stevenson DK, Ergaz Z, Gale R, Pediatrics 1995 96 727 9 7567338
6. Kernicterus in otherwise healthy, breast-fed term newborn. Newman TB, Maisels MJ, Pediatrics 1995 96 730 3 7567339
7. Kernicterus in a full term infant. Penn AA, Enzmann DR, Hahn JS, Stevenson DK, Pediatrics 1994 93 1003 6 7794295 (Pubitemid 24163356)
8. Recurrence of kernicterus in term and near-term infants in Denmark. Ebbesen F, Acta Paediatr 2000 89 1213 7 10.1111/j.1651-2227.2001.tb01368.x 11083378
9. management of hyperbilirubinemia in the healthy term newborn. American Academy of Pediatrics, Provisional Committee for quality improvement and subcommittee on hyperbilirubinemia. Practice parameter, Pediatrics 1994 94 558 65 7755691
10. Accuracy of clinical judgement in neonatal jaundice. Moyer VA, Ahn C, Sneed B, Arch Pediatr Adolesc Med 2000 154 391 4 10768679 (Pubitemid 30198489)
11. The joint use of human and electronic eye: visual assessment of jaundice and transcutaneous bilirubinometry. De Luca D, Zecca E, Zuppa AA, Romagnoli C, Turk J Pediatr 2008 50 456 61 19102050
12. Is Visual Assessment of Jaundice Reliable as a Screening Tool to Detect Significant Neonatal Hyperbilirubinemia? Riskin A, Tamir A, Kugelman A, Hemo M, Bader D, J Pediatr 2008 152 782 7 10.1016/j.jpeds.2007.11.003 18492516
13. Prediction of hyperbilirubinemia in nearterm and term infants. Stevenson DK, Fanaroff AA, Maisels MJ, Young BW, Wong RJ, Vreman HJ, MacMahon JR, Yeung CY, Seidman DS, Gale R, Oh W, Bhutani VK, Johnson LH, Kaplan M, Hammerman C, Nakamura H, Pediatrics 2001 108 31 9 10.1542/peds.108.1.31 11433051 (Pubitemid 32592002)
14. System-based approach to management of neonatal jaundice and prevention of kernicterus. Johnson LH, Bhutani VK, Brown AK, J Pediatr 2002 140 396 403 10.1067/mpd.2002.123098 12006952 (Pubitemid 34494310)
15. Incidence, Course, and Prediction of Hyperbilirubinemia in Near-Term and Term Newborns. Sarici SU, Serdar MA, Korkmaz A, Erdem G, Orna O, Tekinalp G, Yurdakok M, Yigit S, Pediatrics 2004 113 775 780 10.1542/peds.113.4.775 15060227 (Pubitemid 38437383)
16. Transcutaneous bilirubin nomogram for prediction of significant neonatal hyperbiloirubinemia. Varvarigou A, Fouzas S, Skylogianni E, Mantagou L, Bougioukou D, Mantagos S, Pediatrics 2009 124 1052 9 10.1542/peds.2008-2322 19786443
17. Bilirubin screening for normal newborns: a critique of the hour-specific bilirubin nomogram. Fay DL, Schellhase KG, Suresh GK, Pediatrics 2009 124 4 1203 5 10.1542/peds.2009-0190 19786454
18. False-negative results of pre-discharge neonatal bilirubin screening to predict severe hyperbilirubinemia: a need for caution. Slaughter J, Annibale D, Suresh G, Eur J Pediatr 2009 168 12 1461 6 10.1007/s00431-009-0950-z 19255782
19. Early discharge after delivery. A study of safety and risk factors. Zimmerman DR, Klinger G, Merlob P, ScientificWorldJournal 2003 18, 3 1363 9
20. Subcommittee on hyperbilirubinemia. Clinical practice guideline: management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. American Academy of Pediatrics, Pediatrics 2004 114 297 316 15231951
21. Readmission for neonatal jaundice in California, 1991-2000: trends and implications. Burgos AE, Schmitt SK, Stevenson DK, Phibbs CS, Pediatrics 2008 121 4 864 9 10.1542/peds.2007-1214 18381515
22. Clinical report from the pilot USA kernicterus registry (1992 to 2004). Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM, J Perinatol 2009 29 25 S45 19177057
23. Kernicterus in otherwise healthy, breast-fed term newborns. Maisels MJ, Newman TB, Pediatrics 1995 96 730 3 7567339
24. Kernicterus-January 2007 to December 2009. Sgro M, Campbell DM, Fallah S, Shah V, Canadian Paediatric Surveillance Program 2009 Available at: [ http://www.cps.ca/english/surveillance/CPSP/index.htm ]
25. Prospective surveillance study of severe hyperbilirubinaemia in the newborn in the UK and Ireland. Manning D, Todd P, Maxwell M, Platt M-J, Arch Dis Child Fetal Neonatol Ed 2007 92 342 6 10.1136/adc.2006.105361 (Pubitemid 47436215)
26. Predictive ability of a predischarge hourspecific serum bilirubin for subsequent significant hyperbilirubinemia in healthy-term and near-term newborns. Bhutani VK, Johnson L, Sivieri EM, Pediatrics 1999 103 6 14 10.1542/peds.103.1.6 9917432 (Pubitemid 29281921)
27. Skin bilirubin nomogram for the first 96 h of life in a European normal healthy newborn population, obtained with multiwavelength transcutaneous bilirubinometry. De Luca D, Romagnoli C, Tiberi E, Zuppa AA, et al. Acta Paediatr 2008 97 146 150 10.1111/j.1651-2227.2007.00622.x 18254903 (Pubitemid 351197965)
28. An hour-specific nomogram for transcutaneous bilirubin values in term and late preterm Hispanic neonates. Engle WD, Lai S, Ahmad N, Manning MD, Jackson GL, Am J Perinatol 2009 26 6 425 30 10.1055/s-0029-1214238 19263335
29. Transcutaneous bilirubin levels in the first 96 hours in a normal newborn population of 35 weeks' gestation. Maisels MJ, Kring E, Pediatrics 2006 117 1169 1173 10.1542/peds.2005-0744 16585312 (Pubitemid 46071509)
30. Nomogram for prediction of the risk of neonatal hyperbilirubinemia, using transcutaneous bilirubin. Sanpavat S, Nuchprayoon I, Smathakanee C, Hansuebsai R, J Med Assoc Thai 2005 88 1187 1193 16536103 (Pubitemid 43154715)
31. Transcutaneous bilirubin nomogram for predicting neonatal hyperbilirubinemia in healthy term and latepreterm Chinese infants. Yu ZB, Dong XY, Han SP, Chen YL, Qiu YF, Sha L, Sun Q, Guo XR, Eur J Pediatr 2011 170 2 185 91 10.1007/s00431-010-1281-9 20814696
32. Trancutaneous bilirubinometry decreases the need for serum bilirubin measurements and saves money. Maisels MJ, Kring E, Pediatrics 1997 99 599 601 10.1542/peds.99.4.599 9093305 (Pubitemid 27176442)
33. Clinical impact of transcutaneous bilirubinometry as an adjunctive screen for hyperbilirubinemia. Dai J, Krahn J, Parry DM, Clin Biol 1996 29 581 6 (Pubitemid 26398912)
34. Evaluation of discharge management in the prediction of hyperbilirubinemia: the Jerusalem experience. Kaplan M, Bromiker R, Schimmel MS, Algur N, Hammerman C, J Pediatr 2007 150 4 412 417 10.1016/j.jpeds.2006.12.014 17382121 (Pubitemid 46428297)
35. Clinical prediction rules. McGinn T, Guyatt G, Wyer P, Naylor CD, Stiell I, Users' Guide to the Medical Literature: A Manual for Evidence-Based Clinical Practice JAMA and Archives Journals, American Medical Association; Chicago, IL, Guyatt G, Rennie D, 2002 471 48 22308537
36. Prospective validation of a novel strategy for assessing risk of significant hyperbilirubinemia. Gonçalves A, Costa S, Lopes A, Rocha G, Guedes MB, Centeno MJ, Silva J, Silva MG, Severo M, Guimarães H, Pediatrics 2011 127 1 126 31 10.1542/peds.2009-2771 21149428
37. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants. Keren R, Luan X, Friedman S, Saddlemire S, Cnaan A, Bhutani V, Pediatrics 2008 121 170 179 10.1542/peds.2006-3499 18166536
38. Combining clinical risk factors with bilirubin levels to predict hyperbilirubinemia in newborns. Newman T, Liljestrand P, Escobar G, Arch Pediatr Adolesc Med 2005 159 113 9 10.1001/archpedi.159.2.113 15699303 (Pubitemid 40194175)
39. Hyperbilirubinemia in the newborn infant > 35 weeks' gestation: an update with clarifications. Maisels MJ, Bhutani VK, Bogen D, Newman TB, Stark AR, Watcho JF, Pediatrics 2009 124 1193 1198 10.1542/peds.2009-0329 19786452